Pharmacological characterization of VIP receptors in human lung membranes

¹Department of Biochemistry and Nutrition, Medical School, Université Libre de Bruxelles, Belgium.

|March 1, 1988

Abstract:

The ability of VIP, PHI, secretin, helodermin, and seven N-terminally D-amino monosubstituted VIP and PHI analogs to occupy (125I)iodo-VIP labeled receptors and to activate adenylate cyclase was tested on human lung membranes purified by the method of Schachter et al. Best fitted Kd, Kact and % of max. values suggested the coexistence, in near equal proportions, of two classes of VIP-preferring binding sites coupled to adenylate cyclase that showed similar decreasing affinity for: VIP greater than (D-Ala4)-VIP greater than (D-Asp3)-VIP = (D-Ser2)-VIP greater than (D-His1)-VIP greater than PHI greater than (D-Phe2)-VIP greater than (D-Phe4)-VIP. (D-Arg2)-VIP was a non-selective agonist. A third receptor type, coupled to adenylate cyclase and showing high affinity for secretin and helodermin but not for VIP, was also detected.

Related Experiment Videos

Pharmacological characterization of VIP receptors in human lung membranes

Related Concept Videos

Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum.

Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao.

Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon.

Receptor-specific somatostatin analogs: correlations with biological activity.

Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP.

Renal responses to intra-arterial administration of adrenomedullin in dogs.

Galanin signaling in stress-induced brain-gut axis dysregulation: Receptor-specific mechanisms and context-dependent pharmacology.

KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis.

Phoenixin-14 attenuates pancreatic injury by modulating inflammation, oxidative stress, and apoptosis in L-arginine-induced acute pancreatitis.

Endogenous opiates and behavior: 2025.

Sulfakinin neuropeptides and their receptors in insects: Molecular signalling, physiological diversity, and pest management implications.

Altered gastrointestinal function and neurotensin signaling in experimental type 2 diabetes.

Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia.

The safety and efficacy of drug-coated balloon dilation system (Keeway) for benign prostate hyperplasia: a preclinical study.

Pharmacokinetics, mass balance, and metabolism of [14C]SPH3127 (sitokiren), a novel direct renin inhibitor in humans.

Effect of Sodium C-Tetra(propyl)resorcin[4]tetrasulfonate (Na4PRA) on Antituberculosis Drugs as Seen by Diffusometry and NMR Spectroscopy.

Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.

Pharmacodynamics of Boronic Acids and Boronates.

Related Experiment Videos

Pharmacological characterization of VIP receptors in human lung membranes

Abstract:

Related Concept Videos

Related Articles